2017
DOI: 10.5578/khj.10257
|View full text |Cite
|
Sign up to set email alerts
|

A New Marker for Ischemia: Ischemia-modified Albumin

Abstract: ÖZETİskemi modifiye albumin iskemi sonucu oluşan reaktif oksijen türevlerinin yol açtığı albuminde modifikasyon ile oluşur. Albumin kobalt bağlama testi kullanılarak ölçülür. Bu test geçici olmayan kardiyak hasarın başlan-gıcından önce iskeminin erken saptanmasında kullanılır. Bu yazıda iskemi modifiye albuminin patofizyolojisi, analizi ve klinik uygulamalarını inceledik.Anahtar Kelimeler: İskemi modifiye albumin; iskemi; akut koroner sendrom A New Marker for Ischemia: Ischemia-modified Albumin ABSTRACT Ischem… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
4
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 7 publications
(4 citation statements)
references
References 44 publications
(76 reference statements)
0
4
0
Order By: Relevance
“…IMA is useful in cardiac diseases in evaluating early ischemia before the onset of non-transient cardiac damage, preventing progression to infarction, and preventing later complications. Clinical use of IMA in cardiac ischemia is useful, sensitive, cheap, and easy in terms of early diagnosis [30]. There are similar causes such as atherosclerosis and ischemia in the pathogenesis of cardiac and peripheral events.…”
Section: Figure 1 Roc Analysis Of Laboratory Resultsmentioning
confidence: 99%
“…IMA is useful in cardiac diseases in evaluating early ischemia before the onset of non-transient cardiac damage, preventing progression to infarction, and preventing later complications. Clinical use of IMA in cardiac ischemia is useful, sensitive, cheap, and easy in terms of early diagnosis [30]. There are similar causes such as atherosclerosis and ischemia in the pathogenesis of cardiac and peripheral events.…”
Section: Figure 1 Roc Analysis Of Laboratory Resultsmentioning
confidence: 99%
“…Ischaemia-modified albumin, ischaemia and ischaemia-reperfusion injury are caused by oxidative stress, resulting in modification of the N-terminal region of the albumin of reactive oxygen species. 14 In 2003, ischaemia-modified albumin was approved by the Food and Drug Administration as a diagnostic marker for acute myocardial infarction, and it is used in laboratory testing in emergency situations. 14 In a study of 538 patients by Collinson et al ., ischaemia-modified albumin values were found to have 100 per cent sensitivity and 34.5 per cent specificity for the diagnosis of acute myocardial infarction with a troponin measurement.…”
Section: Discussionmentioning
confidence: 99%
“…Cicek et al studied serum mean platelet volume (Cicek, Togan, Akbaba, Narci, & Aygun, 2015), Turedi et al studied plasma SCUBE-1 levels (Turedi et al, 2015), and Yilmaz et al studied plasma d-dimer levels . IMA is caused by reactive oxygen derivatives resulting from ischaemia-modifying albumin (Can & Yosunkaya, 2017). It has been studied in many diseases such as CAD, DM, asthma, COPD and acute coronary syndrome as a marker of diagnostic follow-up and prognosis.…”
Section: Xue Et Al Investigated the Effect Of Gradual Low-flow Repermentioning
confidence: 99%